InsidersTradesSigma
Follow the CalciMedica, Inc. stock price and the full management transaction log of the company, a listed issuer based in United States. Shares trade on the US market, under the supervision of SEC (Form 4). Market capitalisation: €19.6m. The latest transaction was disclosed on 29 June 2026 (Attribution). Among the most active insiders: Roberts Eric W. The full history is free.
96
Insider Decl.
n/a
Thresholds
€3m
77 ops.
Buy Volume
€3,105
9 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CalciMedica, Inc. Buy (bullish), based on 2 analysts. Average price target: US$10.50.
46Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 29 June 2026
Declarations96 total
1,182,621 sharesCommon StockSEC:0001189022-26-000002:0
248,972 sharesCommon StockSEC:0001267959-26-000003:0
Canonical exit: 23 Sept 2026 (T+90)
186,729 sharesCommon StockSEC:0001484729-26-000004:0
186,729 sharesCommon StockSEC:0001576244-26-000004:0
124,486 sharesCommon StockSEC:0001968793-26-000004:0
2,500 shares@ US$3.070.8% of flowCommon StockSEC:0001576244-25-000007:0
Canonical exit: 17 Dec 2025 (T+90)
3,400 shares@ US$2.67790.9% of flowCommon StockSEC:0001576244-25-000005:0
Canonical exit: 14 Dec 2025 (T+90)
5,000 shares@ US$3.121.6% of flowCommon StockSEC:0001576244-25-000003:0
Canonical exit: 11 Dec 2025 (T+90)
2,343 shares@ US$3.14880.8% of flowCommon StockSEC:0001415889-25-024256:0
Canonical exit: 8 Dec 2025 (T+90)
9,200 shares@ US$2.8632.9% of flowCommon StockSEC:0001415889-25-023364:0
Canonical exit: 26 Nov 2025 (T+90)
3,508 shares@ US$2.79281.1% of flowCommon StockSEC:0001415889-25-022850:0
Canonical exit: 19 Nov 2025 (T+90)
1,000 shares@ US$2.790.3% of flowCommon StockSEC:0001415889-25-022550:0
Canonical exit: 17 Nov 2025 (T+90)
9,563 shares@ US$2.819416.0% of flowCommon StockSEC:0001415889-25-022549:0
Canonical exit: 17 Nov 2025 (T+90)
5,076 shares@ US$2.89771.6% of flowCommon StockSEC:0001415889-25-022261:0
Canonical exit: 13 Nov 2025 (T+90)
1,584 shares@ US$2.5852.9% of flowCommon StockSEC:0001415889-25-022159:0
Canonical exit: 12 Nov 2025 (T+90)
1,000 shares@ US$3.6566.5% of flowCommon StockSEC:0001415889-25-020458:0
1,500 shares@ US$3.7750.6% of flowCommon StockSEC:0001415889-25-020164:0
Canonical exit: 20 Oct 2025 (T+90)
1,500 shares@ US$3.370.6% of flowCommon StockSEC:0001415889-25-020111:0
Canonical exit: 19 Oct 2025 (T+90)
1,000 shares@ US$3.400.6% of flowCommon StockSEC:0001415889-25-020052:0
Canonical exit: 19 Oct 2025 (T+90)
4,500 shares@ US$2.871.3% of flowCommon StockSEC:0001415889-25-019998:0
Canonical exit: 16 Oct 2025 (T+90)
2,000 shares@ US$2.880.7% of flowCommon StockSEC:0001415889-25-019997:0
Canonical exit: 16 Oct 2025 (T+90)
6,500 shares@ US$2.43231.8% of flowCommon StockSEC:0001415889-25-019822:0
Canonical exit: 12 Oct 2025 (T+90)
2,500 shares@ US$2.471.1% of flowCommon StockSEC:0001415889-25-019816:0
Canonical exit: 12 Oct 2025 (T+90)
5,000 shares@ US$1.60470.9% of flowCommon StockSEC:0001415889-25-019655:0
Canonical exit: 7 Oct 2025 (T+90)
1,000 shares@ US$1.85100.0% of flowCommon StockSEC:0001415889-25-019190:0
Canonical exit: 29 Sept 2025 (T+90)
25 of 96 declarations
About CalciMedica, Inc.
CalciMedica, Inc. is a biopharmaceutical company focused on developing treatments for diseases related to calcium regulation. It is listed on NASDAQ under the ticker XNAS.